About: Severe adverse reactions are rare with infusions of infliximab in a community setting

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Severe adverse reactions are rare with infusions of infliximab in a community setting Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebn/2010/volume_13/issue_4/w
Subject	Prevalence
Title	Severe adverse reactions are rare with infusions of infliximab in a community setting
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebn/2010/volume_13/issue_4/B3559945310A7E61E053120B220A02A9/m/web http://hub.abes.fr/bmj/periodical/ebn/2010/volume_13/issue_4/B3559945310A7E61E053120B220A02A9/m/print
related by	http://hub.abes.fr/bmj/periodical/ebn/2010/volume_13/issue_4/B3559945310A7E61E053120B220A02A9/authorship/1
Abstract	Commentary on: DucharmeJPelletierCZachariasR. The safety of infliximab infusions in the community setting. Can J Gastroenterol2010;24:307-11.
article type	other
publisher identifier	ebnurs1002
is part of this journal	Evidence Based Nursing
PubMed ID	20876789

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata